… OBJECTIVES: To evaluate and compare the efficacy and tolerability of meglumine
antimoniate, pentamidine isethionate, and amphotericin B in the treatment of ATL caused by …

… meglumine antimoniate (Glucantime; Rhone Poulenc Rorer, Paris, France) in a 1:1 allocation.
Pentamidine … Pentamidine isethionate consisted of 300 mg of lyophilized powder that was …

… He was finally treated successfully with a combination of L-AmB, meglumine antimoniate,
and pentamidine isethionate. It is important to include asplenia as an immunosuppressive …

… , meglumine antimoniate is the first drug of choice for mucosal leishmaniasis treatment followed
by amphotericin B and pentamidine isethionate. We … with meglumine antimoniate failed. …

… , meglumine antimoniate is the first drug of choice for mucosal leishmaniasis treatment followed
by amphotericin B and pentamidine isethionate. We … with meglumine antimoniate failed. …

… Background: Pentavalent antimonial derivatives (PAD), especially meglumine antimoniate
(… Objective: To evaluate the efficiency and tolerance of pentamidine isethionate in Old World …

… Six attempts at intralesional injections of meglumine antimoniate at 2-week intervals were
… In March 2007, the patient was treated with intramuscular pentamidine isethionate at a daily …

… and toxicity of meglumine antimoniate, aminosidine sulphate and pentamidine isethionate,
a … Group 1 received pentamidine 4 mg/kg/every 2 days, for 8 applications; Group 2 received …

… meglumine antimonate (infected control subjects; 10 mg of antimony/ kg intramuscularly,
twice a day for 20 days), pentamidine (2 … Pentamidine isethionate (a solution of 300 mg of total …

… one and two injections of pentamidine isethionate, at 7 mg/… one and two injections of
pentamidine isethionate, at 7 mg/kg … trial comparing meglumine antimoniate, pentamidine and …